Skip to main content
. 2020 May 20;23(5):321–332. doi: 10.3779/j.issn.1009-3419.2020.104.02

1.

1

Kaplan-Meier analysis of the factors affecting OS in advanced stage NSCLC patients. A: PS (P < 0.000, 01). Median survival: PS 3-4: 26 d; PS 2: 68 d; PS 1: 176 d; PS 0: > 365 d. 1 year survival rate: PS 3-4: 42.9%; PS 2: 21.1%; PS 1: 60%; PS 0: 78.6%. B: clinical stage (P=0.000, 78). Median Survival: IVb: 58 d; IVa: 263 d; IIIb: > 365 d; 1 year survival rate: IVb: 27.6%; IVa: 65%; IIIb: 100%; C: Metastasis (P=0.000, 78). Median survival: M1b: 58 d; M1a: 263 d; M0: > 365 d; 1 year survival rate: M1b: 27.6%; M1a: 65%; M0: 100%. OS: overall survival; PS: performance status; NSCLC: non-small cell lung cancer.